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Background/aim: To elucidate the early surgical advantages of a 23-gauge trocar combined with a one-directional valve system in
transconjunctival pars plana vitrectomies.
Materials and methods: Early surgical results of 432 eyes of 432 patients (190 female and 242 male) who underwent 23-gauge (23G)
transconjunctival sutureless vitrectomies (TSV) were evaluated. Sixty-three patients out of 432 underwent a second operation, 29 of
them underwent silicone oil extraction, and 34 had phacoemulsification surgery with the help of vitreous infusion. If any sign of leakage
was observed after the withdrawal of the cannulae, a suture was applied at the conjunctiva-scleral opening site.
Results: A total of 21 (4.8%) patients in the first operation and 7 (11.1%) cases in the second operation needed suture in at least 1
sclerotomy site. No one had intraoperative hypotony. On postoperative day 1, 37 initial surgery patients and 3 second TSV patients had
hypotony; all of them resolved spontaneously 1 week after surgery. No one developed choroidal effusions or detachment. Intraocular
pressure spikes more than 22 mmHg in day 1 occurred in 18 eyes after initial TSV; 6 of them had gas and 4 eyes had silicone tamponade.
Conclusion: 23G TSV is an effective and safe procedure for both first vitreoretinal surgery and second intraocular surgeries in eyes that
had TSV previously.
Key words: 23G trocar, pars plana vitrectomy, postoperative hypotonia

1. Introduction
After Eckard’s description of a 23–gauge (23G) selfsealing sutureless transconjunctival pars plana vitrectomy
technique in 2005, it has been widely used in vitreoretinal
surgery (1,2).
Owing to the small incision and lack of suture, 23G
transconjunctival sutureless vitrectomy (TSV) decreases
surgical time and minimizes surgical trauma, which
decreases postoperative inflammation, patient discomfort,
and postoperative recovery time. In addition, woundrelated complications such as leakage, intraoperative and
postoperative hypotony, risk of endophthalmitis, irritation
due to sutures, and subconjunctival silicone oil and scleral
pigmentary changes could also be avoided.
To stabilize intraocular pressure (IOP) during surgery
and to achieve more stabilized wound configuration,
a specially-designed 23G trocar combined with a
1-directional valve system with a cap was chosen.
To elucidate surgical advantages, we report the early
results of our patients who underwent TSV in both
primary operations and reoperations.
* Correspondence: habasa@yahoo.com
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2. Materials and methods
In this study, 23G TSV with a 1-step trocar combined
with a 1-way valve system with a cap (DORC, Holland)
was performed in 432 eyes of 432 patients. All patients
provided informed consent before the operation. A total
of 432 patients (190 female and 242 male) were included in
this study. The mean age was 68.12 ± 12.4 years (minimum
48, maximum 79) (Table 1).
All patients underwent a complete ophthalmic
examination, including pre- and postoperative visual
acuity, IOP measurement, and anterior and posterior
segment examinations. Hypotony was defined as IOP
equal to or less than 6 mmHg.
The indications for vitrectomy were vitreous
hemorrhage, proliferative diabetic retinopathy, both
tractional and rhegmatogenous retinal detachment,
epiretinal membrane, macular hole, dropped IOL, or
nucleus extraction and silicone oil removal.
A posterior sub-Tenon’s injection was performed for
anesthesia in all patients at the inferonasal quadrant. The
surgical approach consisted of displacing the conjunctiva
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Table 1. Demographic findings of patients and follow-up periods for primary and secondary TSV.
Patients n = 432

190 females, 242 males

Mean age: 68.12 ± 12.4 years (48–79)

Female 67.69 ± 10.5 years (48–76)
Male 69.12 ± 13.2 years (49–79)

Mean follow-up period: 12.7 months (7–36)

Primary TSV mean 14.6 months (9–36)
Secondary TSV mean 9.8 months (7– 29)

about 2–3 mm laterally using a specially designed pressure
plate (DORC, Holland) to stabilize the eye and hold the
conjunctiva firmly to the sclera. Than a 20–30° angled
tunnel incision was made through the conjunctiva, sclera,
and pars plana, 3.5 mm from the corneoscleral limbus
with a specially designed 23G sharp trocar overlying
cannula combined with a valve system with a cap on it.
The scleral incisions were made in the inferotemporal,
superotemporal, and superonasal quadrants, obliquely
parallel to the corneoscleral limbus (Figure 1). The
infusion cannula was inserted into the inferotemporal
quadrant while superior incisions were used for insertion
of surgical manipulation devices such as a vitrectomy
probe, endoillumination probe, back-flush needle,
endodiathermia probe, and endolaser probe. With the help
of a valve system, the plug insertion into the trocar system
was not performed and hypotony was never encountered
during the surgery (Figure 2).
At the end of the surgery, the cannulae were withdrawn
with specially designed cannular forceps (DORC,
Holland). Gentle pressure with a cotton tip applicator was
applied on the scleral tunnel incision site without extra
intervention. To enhance the sealing of the conjunctivascleral incision, the displaced conjunctiva was returned
to its original position. When subconjunctival bleeding

was observed, a short tamponade with gentle pressure
and a cotton tip applicator over the bleeding site was
applied until the hemorrhage was stopped. If any sign of
leakage was observed, suture was applied at the previous
conjunctiva-scleral opening. At the end of the surgery,
an antibiotic and steroid combination was injected into
the inferonasal quadrant that was used for posterior subTenon’s anaesthesia. All operations had been performed
with same technique and by the same experienced
surgeons who participated in this study.
Sulfur hexafluoride (SF6) was used in 136 eyes,
octafluoropropane (C3F8) was used in 198 eyes, air was
used in 13 eyes, and silicone oil was injected in 64 eyes.
Twenty-one eyes in the initial operation and 63 patients
who underwent a second operation left with BSS, in which
any fluid–gas exchange was not performed.

Figure 1. Tunnel incision by 23G sharp trocar overlying cannula
combined with valve system.

Figure 2. Cannulae with cap.

3. Results
All patients were evaluated for surgical safety and surgeryrelated problems, such as incision-related problems
and anterior and/or posterior segment problems both
intraoperatively and postoperatively. Sutures were required
in a total of 21 (4.8%) patients with at least 1 sclerotomy,
due to intraoperative wound leakages. Suture was needed
in only 1 sclerotomy for 10 eyes (2.3%), while 6 eyes
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(1.3%) underwent closure of 2 sclerotomy sites and 5 eyes
(1.1 %) required sutures in all 3 sclerotomy sites. Out of
37 sutures, 18 suture placements (48.6%) were performed
in the superior quadrant on the dominant hand side, 12
sutures (32.4%) were necessary on the nondominant
hand side, and only 7 sutures (18.9%) were needed in the
inferotemporal quadrant, which was used for infusion
cannulae.
All the cannulae remained stable in their appropriate
place. No slippage or loss of the cannulae or any other
anterior segment complication, such as damage to the
crystalline lens by the cannulae, was observed.
No one had intraoperative hypotony, thanks to the
help of the specially designed 1- directional valve cannula
system with a cap, in which only outer-to-inner passage
is possible. Therefore, no one had retinal or vitreous
hemorrhage due to intraoperative decompression.
Intraoperative tears on sclerotomies did not develop as a
posterior segment related complication of cannulae.
Diathermia through the conjunctival opening at the
end of operation was not performed in any case. No one
had required postoperative suture placement during
the follow-up period for bleb formation as a sign of
subconjunctival leakage of gas tamponade or silicone oil.
Thirty-seven patients (8.5%) had hypotony after
primary TSV on postoperative day 1, and 3 patients had
hypotony after the second operation; all of them resolved
spontaneously 1 week after surgery. Out of 37 eyes, 17
eyes had SF6, 14 eyes had C3F8, and 6 eyes had BSS as
a vitreous tamponade. In eyes filled with SF6, 6 eyes
underwent surgery for the epiretinal membrane, 6 eyes for
vitreous hemorrhage, 3 eyes for macular holes, and 2 eyes
for proliferative diabetic retinopathy. In eyes with C3F8, 7
eyes underwent surgery for epiretinal membrane peeling,
4 eyes for macular holes, 2 eyes for vitreous hemorrhage,
and 1 eye for proliferative diabetic retinopathy. Four eyes

that were operated on for vitreous hemorrhage and 2 eyes
for dropped IOL extraction in whom no tamponade was
used developed temporary hypotony. Three patients who
had hypotony after the second surgery for silicone oil
extraction were also left without any tamponade (Table
2). Nine patients with hypotony had sclerotomy sutures
at in least 1 sclerotomy; 6 of them had only 1 suture and
3 had 2 sutures. No one developed choroidal effusion or
detachment due to leakage and hypotony postoperatively
at any time during the follow-up period. Vitreous or
retinal incarceration or endophthalmitis was not observed
in any case.
Three patients who had degenerative myopia did not
develop sclerotomy-related problems such as leakage or
hypotony during the follow-up period. Suture placements
were not required in any of them.
A total of 63 patients underwent further intraocular
surgery; 29 of them had undergone silicone oil extraction
operation and 34 phacoemulsification surgery after
TSV surgery. Three sclerotomy incisions were done for
silicone oil removal and 1 sclerotomy was performed in
the inferotemporal quadrant for insertion of an infusion
cannula to use for stabilizing the anterior chamber and to
prevent its excessive deepening during phacoemulsification.
The mean time for the second operation was 6.4 months
(9 weeks–13 months) after TSV. We did not have any
difficulties in performing new sclerotomies and corneal
incisions in the second operations and did not observe
any problems related to previous sclerotomies, such as
reopening, leakage, or hypotony during the operation and
or the follow-up period in any patient who had or had
not sutures in previous surgery. Only 7 (11%) patients out
of 63 needed sutures for scleral closure. All of them had
undergone silicone oil extraction. Four patients had also
needed suture placement in the initial surgery, while 3 had
not.

Table 2. Surgical indications and vitreous tamponade in eyes that had postoperative hypotony after primary and
secondary TSV.

Primary TSV
n = 37

SF6

C3F8

BSS

ERM = 6
VH = 6
MH = 3
PDR =2

ERM = 7
MH = 4
VH = 2
PDR = 1

VH = 4
IOL dropped extraction = 2

Secondary TSV
n=3
TSV: Transconjunctival sutureless vitrectomy.
ERM: Epiretinal membrane.
MH: Macular hole.
VH: Vitreous hemorrhage.
PDR: Proliferative diabetic retinopathy.
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Silicon oil extraction = 3
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The mean preoperative IOP was 13.15 ± 8.7 mmHg (9–
18 mmHg) and mean postoperative IOP was 10.8 ± 4.15
mmHg (5–28 mmHg) 1 day after surgery and it was 14.36
± 5.12 mmHg (10–20 mmHg) after 1 month.
A total of 40 patients had hypotony on postoperative
day 1, and all of them resolved without treatment in 1
week. No one developed choroidal effusion or detachment
after either surgery. Intraocular pressure spikes more than
22 mmHg occurred in 18 eyes (4.1%) on postoperative day
1; 6 of them (1.3%) had a gas tamponade and 4 eyes (0.9%)
had silicone oil. No one needed another intervention, such
as silicone oil removal for increased IOP. IOP spikes after
the second surgery were not observed and no one had
IOP-related complications after either surgery (Table 3).
4. Discussion
For a wide variety of vitreoretinal surgical indications,
23G TSV is a safe and effective surgical technique. In this
study, we applied the 23G TSV technique to patients for
both primary surgeries and reoperations. A total of 21
(4.8%) eyes out of 432 required suturing due to leakage
after removal of cannulae in the initial operation and 7 out
of 63 (11%) had scleral sutures in the second operation.
Although the incidence of suture requirements was
higher in the second operation group than in the initial
surgery group in our series, the number of patients in each
operation group was not comparable; therefore, statistical
analysis was not performed. Chieh et al. reported that 38%
of 118 eyes required suture placements and the suture
placement incidence was 15% in Singh et al.’s series of 93
patients (3,4). Gupta et al. reported that sclerotomy sutures
were required intraoperatively in 22% out of 92 patients
(5). Woo et al. performed suture placements in 11.2% of
their patients, and found that a younger age (less than
50 years), vitreous base dissection, and history of prior
vitrectomy were risk factors for requirement of suture
placement (6). The mean age of our patients was 68.12 ±
12.4 and a total of 24 patients were younger than 50 years
old. Even if we did not observe any difference in the young
age group, the number of young patients in our study was
much lower than that of the older patients and therefore
no statistical evaluation was possible.

Parolini et al. observed requirement of suture
placements in 3.9% of their patients (7). Erakgun and
Egrilmez reported that 3% of their 40 patients required
sutures (8), but they observed silicone oil migration to the
subconjunctival space in some.
Postoperative leakage may be associated with some
important complications, such as reduced endotamponade
effect, postoperative chemosis, discomfort, and interference
with subsequent glaucoma filtering surgery. To avoid
possible complications, we prefer transconjunctival suture
placement, most of them for preventive purposes in our
patients. Even though our incidence of suture placements
in both initial and second operations was lower than those
of some other authors’ series, the suture incidence in initial
surgery was little higher but still correlated with Parolini’s
and Erakgun’s series. Fortunately, we did not observe
any silicone oil migration under the conjunctival space
and subconjunctival leakage that could have caused bleb
formation in either the initial or the second operation.
Wound leaks and hypotony may cause an influx of
bacteria that increases the risk of endophthalmitis. We did
not observe endophthalmitis in our series; we propose that
TSV does not increase the risk of endophthalmitis. Fine
et al. observed 1 case of sterile endophthalmitis in their
series of 77 cases, which was less than our total number
of cases (9).
We observed transient early postoperative hypotony
in day 1 in 37 cases (8.5%) after initial TSV. All of them
resolved spontaneously in 1 week, which was also the
most common complication in our series. Schweitzer
et al. observed postoperative hypotony in 21.1% of their
cases; postoperative hypotony was the most common
complication in their series also (10). Postoperative
hypotony was observed in 6.5% of cases in Gupta et al.’s
series and 3.4% in Chieh et al.’s series (3,5). It was seen
in 3 out of 164 cases in de Preobrajensky et al.’s report
and 4 cases out of 50 (8%) in Misra et al.’s series (11,12).
Our postoperative hypotony incidence is correlated with
other series. Woo et al. observed postoperative hypotony
in 11.3% of cases at 2 h, 6.5% at 5 h, and 3.8% at day 1
(6). It is well known that the level of IOP may change due
to diurnal variation. Moreover, postoperative hypotony

Table 3. Distribution of suture requirements and IOP changes after primary and secondary TSV.
Primary TSV (n = 432)

Secondary TSV (n = 63)

Suture requiring leakage

21 (4.8%)

7 (11.1%)

Postoperative hypotony (≤6 mmHg)

37 (8.5%)

3 (4.7%)

Postoperative IOP spike (>22 mmHg)

18 (4.1%)

0

TSV: Transconjunctival sutureless vitrectomy.
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depends on several other factors such as surgical technique,
indication, equipment, and intraocular tamponades.
Therefore, the incidence of hypotony may vary in different
series. All of our operations were performed with the same
technique and equipment and by the same experienced
surgeons. Due to a low number of patients who developed
hypotony after surgery with different indications using
different tamponades, we could not statistically analyze
the relationship between these factors in our study.
Choroidal detachment did not develop in our series.
Parolini et al. observed 1 choroidal detachment (0.1%) in
their 943 cases, and it spontaneously resolved 1 week after
surgery (7). Two eyes of 114 patients (1.7%) developed
choroidal effusion in Chieh et al.’s series (3).
A total of 63 patients in our series underwent further
surgery after initial TSV; we did not have any difficulties
in performing new sclerotomies and/or corneal incisions
in second operations. Even though the shortest time
between the initial and the second operation was a little
longer than 1 month, no problems related to previous

sclerotomies, such as reopening and leakage during
the second operation under pressure, were observed.
According to our observation, a 1-month period is
sufficient for sclerotomy healing between 2 operations and
suture placement incidences in the second operation were
not related to having a suture in the initial operation.
Severe subconjunctival hemorrhage, suture related
inflammation, and conjunctival scarring were not
observed in our series in the initial operation or after the
reoperation period.
Owing to small incisions and a lack of sutures in most
of the patients, 23G TSV minimizes surgical trauma,
improves patient comfort, decreases suture related
inflammation, and diminishes long-term conjunctival
scarring with proper scleral wound healing.
According to the early postoperative results of our
observation, 23G TSV with a valved trocar system is a
safe procedure for wound closure, intraocular pressure
stabilization, and ocular complications due to hypotony
for both initial operations and reoperations.

References
1.

Kim MJ, Park KH, Hwang JM, Yu HG, Yu YS, Chung H. The
safety and efficacy of transconjunctival sutureless 23-gauge
vitrectomy. Korean J Ophthalmol 2007; 21: 201–207.

8.

Erakgun T, Egrilmez S. Surgical outcomes of transconjunctival
sutureless 23- gauge vitrectomy with silicone oil injection.
Indian J Ophthalmol 2009; 57: 105–109.

2.

Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy.
Retina 2005; 25: 208–211.

9.

3.

Chieh JJ, Rogers AH, Wiegand TW, Baumal CR, Reichel
E, Duker JS. Short-term safety of 23-gauge single-step
transconjunctival vitrectomy surgery. Retina 2009; 29: 1486–
1490.

Fine HF, Iranmanesh R, Iturralde D, Spaide RF. Outcomes of
77 consecutive cases of 23-gauge transconjunctival vitrectomy
surgery for posterior segment disease. Ophthalmology 2007;
114: 1197–1200.

10.

Schweitzer C, Delyfer MN, Colin J, Korobelnik JF. 23-gauge
transconjunctival sutureless pars plana vitrectomy: results of a
prospective study. Eye 2009; 23: 2206–2214.

11.

de Preobrajensky N, Mrejen S, Adam R, Ayello-Scheer S,
Gendron G, Rodallec T, Sahel JA, Barale PO. 23-Gauge
transconjunctival sutureless vitrectomy: a retrospective study
of 164 consecutive cases. J Fr Ophthalmol 2010; 33: 99–104
(article in French with an abstract in English).

12.

Misra A, Ho-Yen G, Burton RL. 23-Gauge sutureless vitrectomy
and 20-gauge vitrectomy: a case series comparison. Eye 2009;
23: 1187–1191.

4.

Singh CN, Iezzi R, Mahmoud TH. Intraocular pressure
instability after 23- gauge vitrectomy. Retina 2010; 30: 629–634.

5.

Gupta OP, Ho AC, Kaiser PK, Regillo CD, Chen S, Dyer
DS, Dugel PU, Gupta S, Pollack JS. Short-term outcomes of
23-gauge pars plana vitrectomy. Am J Ophthalmol 2008; 146:
789–790.

6.

Woo SJ, Park KH, Hwang JM, Kim JH, Yu YS, Chung H. Risk
factors associated with sclerotomy leakage and postoperative
hypotony after 23-gauge transconjunctival sutureless
vitrectomy. Retina 2009; 29: 456–463.

7.

Parolini B, Prigione G, Romanelli F, Cereda MG, Sartore M,
Pertile G. Postoperative complications and intraocular pressure
in 943 consecutive cases of 23-gauge transconjunctival pars
plana vitrectomy with 1-year follow-up. Retina 2010; 30: 107–
111.

900

